IMbassador250: A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Sweeney, C. J.; Gillessen, S.; Rathkopf, D.; Matsubara, N.; Drake, C.; Fizazi, K.; Piulats, J. M.; Wysocki, P. J.; Buchschacher, G. L. Jr; Doss, J.; Mariathasan, S.; Kadel, E. E.; Yuen, K.; Datye, A.; Rasuo, G.; Tayama, D.; Williams, P.; Powles, T. |
| Abstract Title: | IMbassador250: A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC) |
| Meeting Title: | 111th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 80 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2020 Apr 27-28/Jun 22-24 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-08-01 |
| Language: | English |
| ACCESSION: | WOS:000590059302156 |
| DOI: | 10.1158/1538-7445.Am2020-ct014 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT014 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos |
